1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow BL1107 High dose: new trials by email Literature Review of BL1107 High dose trials Research Report on BL1107 High dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension BL1107 Low dose, BL1107 High dose, Timolol maleate 0.5% - Glaucoma | Phase 2 | Completed | Bausch & Lomb Incorporated | 252 | 2025-10-24 | 2026-07-22 |
Glaucoma (1)
Bausch & Lomb Incorporated (1)
United States (1)